EML4 and non-small cell lung carcinoma: To identify adaptive response mechanisms, we examined the landscape of tyrosine phosphorylation upon acute LOR treatment in EML4-ALK-positive NSCLC cell lines using PamGene microarray peptide assay, known as protein tyrosine kinase (PTK) (Fig. 1A).